Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Spinnovation Biologics Beats Targets

Spinnovation BiologicsEchoing a trend in the growth of biologics and biosimilars market, technology provider Spinnovation Biologics has tripled its client base over the past twelve months. This growth has come from within biotech and pharma industries focused on the research, development and manufacture of biologics products, and has led to an increased demand for the company's Spedia-NMRTM spent media service. The success has allowed the company to expand into the US bioprocess and biologics markets, with its first permanent business development presence in Pennsylvania.

Spinnovation Biologics is renowned for its expertise in ‘Spent Media Analysis' with Spedia-NMRTM. This technology delivers detailed, rapid, cost-effective, quantitative and multiplex analysis of cell culture media.  The growing interest from pharma/biotech has come from a need to trouble-shoot problems during bioprocess development and to optimise feeding strategies for biologics manufacture and for the preparation of clinical trial batches.  The Spedia-NMRTM technology's rapid turnaround, in evaluation of cell culture media components, metabolites and concentrations is addressing unmet needs for biologics and biosimilar production.

Spinnovation's reputation and outstanding service impressed Bram Bout, Chief Technology Officer at Profibrix who said, "Spinnovation's Spedia-NMRTM service gave us rapid and efficient access to the concentration profiles of feed components and metabolites relevant to fine tune our cell culture process." and Vivalis declared: "The Spedia-NMRTM service brings  new insights into our cell lines metabolism which enables us to further optimize its performance."

Dr Frederic Girard, CEO and co-founder of Spinnovation commented, "Spedia-NMRTM has come at an important time for the biologics and biosimilars industry and as we engage with more teams in this sector, we're seeing additional ways to develop the technology and associated services even further to meet specific challenges in development, production and manufacturing."

To find out more about how Spinnovation can help with your product and process bioanalysis projects, please visit www.spinnovation-biologics.com

Spedia-NMRTM is a registered trademark of Spinnovation Analytical BV


 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events